Family Medicine · Steele, MO
NPI
1245264696
Since 2006
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
216 W Main St
Steele, MO, 63877
Phone (573) 695-2181
Groups this clinician bills Medicare through
Medicare paid, 2024
$396K
9,952 services
Medicare patients, 2024
674
Average age 66
Drug cost, 2024
$1.9M
28,299 prescriptions
Company payments, 2025
$2,154
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Timothy W McPherson was code J1010 (injection, methylprednisolone acetate, 1 mg), 842 times for 13 patients. In total Timothy W McPherson billed 9,952 services in 182 codes, and Medicare paid $396K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-02-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 842 | 13 | $0.09 | $76.2 |
| 80307 Drug Tests | Office | 751 | 374 | $60.75 | $46K |
| 99214 Office E&M - Established | Office | 543 | 129 | $87.21 | $47K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 535 | 331 | $241.54 | $129K |
| 99213 Office E&M - Established | Office | 315 | 98 | $57.48 | $18K |
| 71046 X-ray - Chest | Office | 140 | 124 | $17.82 | $2,494 |
| 93000 Electrocardiogram | Office | 115 | 106 | $6.76 | $777 |
| 95816 Neurologic | Office | 115 | 29 | $256.53 | $30K |
| 96112 Behavioral Health Services | Office | 107 | 29 | $90.49 | $9,682 |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 105 | 93 | $111.16 | $12K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 101 | 65 | $11.95 | $1,207 |
| 90901 Behavioral Health Services | Office | 89 | 19 | $26.48 | $2,357 |
| 93306 Echocardiography (TTE/TEE) | Office | 89 | 87 | $120.12 | $11K |
| 85025 Blood Count | Office | 80 | 64 | $7.61 | $609 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 79 | 24 | $0.08 | $6.15 |
By year: 2022 $390K for 16,430 services; 2023 $429K for 9,437 services; 2024 $396K for 9,952 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80307 Drug Tests | 751 | 374 | $60.75 | $46K |
| G0483 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 535 | 331 | $241.54 | $129K |
| G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 105 | 93 | $111.16 | $12K |
| 85025 Blood Count | 80 | 64 | $7.61 | $609 |
| G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 36 | 33 | $153.46 | $5,525 |
| 80053 Clinical Chemistry | 34 | 25 | $10.35 | $352 |
| 36415 Venipuncture Blood Collection | 33 | 26 | $8.65 | $285 |
| 84443 Clinical Chemistry | 26 | 19 | $16.46 | $428 |
| 80061 Clinical Chemistry | 20 | 16 | $13.12 | $262 |
| 81002 Clinical Chemistry | 15 | 13 | $3.41 | $51.15 |
Medicare prescription drug claims, 2024
In 2024, the drug Timothy W McPherson prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 4,927 prescriptions and refills. In total Timothy W McPherson wrote 28,299 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 4,927 | 4,927 | 796 | $166K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,367 | 1,367 | 200 | $41K |
| Pregabalin Generic | 1,263 | 1,269 | 222 | $27K |
| Gabapentin Generic | 838 | 878 | 277 | $8,975 |
| Rosuvastatin Calcium Generic | 821 | 1,083 | 139 | $4,523 |
| Pantoprazole Sodium Generic | 536 | 646 | 96 | $3,380 |
| Alprazolam Generic | 536 | 536 | 153 | $2,131 |
| Furosemide Generic | 460 | 505 | 86 | $1,821 |
| Levothyroxine Sodium Generic | 450 | 558 | 73 | $2,661 |
| Atorvastatin Calcium Generic | 425 | 613 | 101 | $2,141 |
| Lisinopril Generic | 409 | 498 | 86 | $1,637 |
| Clopidogrel Clopidogrel Bisulfate | 408 | 474 | 59 | $2,734 |
| Metformin Hcl Generic | 371 | 481 | 76 | $1,483 |
| Omeprazole Generic | 367 | 444 | 67 | $2,930 |
| Amlodipine Besylate Generic | 358 | 477 | 68 | $1,371 |
Brand drugs: 3,512 claims; generic drugs: 24,611 claims; opioid claims: 7,089.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Timothy W McPherson $2,154 ($2,154 in general payments such as food, travel and fees) from 25 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $279.
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 15 | $279 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $204 |
| Amgen Inc. AMGN | 15 | $168 |
| Pfizer Inc. PFE | 14 | $165 |
| Merck Sharp & Dohme LLC MRK | 10 | $164 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 6 | $156 |
| Lundbeck LLC | 8 | $152 |
| Viatris Specialty LLC | 6 | $112 |
| Sumitomo Pharma America, Inc. 4506.T | 4 | $105 |
| Grifols USA, LLC | 4 | $103 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.